1
|
Melexopoulou C, Filiopoulos V, Marinaki S. Therapeutic apheresis in renal transplantation: An update. Transfus Apher Sci 2024; 63:103844. [PMID: 37978039 DOI: 10.1016/j.transci.2023.103844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2023]
Abstract
Therapeutic apheresis (TA) plays a significant role in various aspects of renal transplantation. It has been a necessary preconditioning component in ABO incompatible kidney transplants and an important modality in the removal of anti-human leukocyte antigen (HLA) antibodies both in the context of desensitization protocols that have been developed to allow highly sensitized kidney transplant candidates to be successfully transplanted and as treatment of antibody mediated rejection episodes post transplantation. In addition, TA has been used with various results for the management of recurrent focal segmental glomerulosclerosis. The purpose of this review is to examine the evidence supporting the application of TA as an adjunctive therapeutic option to immunosuppressive agents in protocols both before and after kidney transplantation.
Collapse
Affiliation(s)
- Christina Melexopoulou
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
| | - Vassilis Filiopoulos
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
| | - Smaragdi Marinaki
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
| |
Collapse
|
2
|
Melexopoulou C, Filiopoulos V, Marinaki S. Therapeutic apheresis in renal transplantation: An update. Transfus Apher Sci 2023:103852. [PMID: 38008686 DOI: 10.1016/j.transci.2023.103852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2023]
Abstract
Therapeutic apheresis (TA) plays a significant role in various aspects of renal transplantation. It has been a necessary preconditioning component in ABO incompatible kidney transplants and an important modality in the removal of anti-human leukocyte antigen (HLA) antibodies both in the context of desensitization protocols that have been developed to allow highly sensitized kidney transplant candidates to be successfully transplanted and as treatment of antibody mediated rejection episodes post transplantation. In addition, TA has been used with various results for the management of recurrent focal segmental glomerulosclerosis. The purpose of this review is to examine the evidence supporting the application of TA as an adjunctive therapeutic option to immunosuppressive agents in protocols both before and after kidney transplantation.
Collapse
Affiliation(s)
- Christina Melexopoulou
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
| | - Vassilis Filiopoulos
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
| | - Smaragdi Marinaki
- Department of Nephrology & Renal Transplantation, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece
| |
Collapse
|
3
|
Gong N, Zhao Y, Zhu H, Wang C. Editorial: Novel mechanisms and approaches in kidney/pancreas-kidney transplant-related injury. Front Immunol 2022; 13:1082590. [PMID: 36483561 PMCID: PMC9724645 DOI: 10.3389/fimmu.2022.1082590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Accepted: 11/07/2022] [Indexed: 11/23/2022] Open
Affiliation(s)
- Nianqiao Gong
- Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, National Health Commission and Chinese Academy of Medical Sciences, Wuhan, China,*Correspondence: Nianqiao Gong, ; Yuanyuan Zhao, ; Hua Zhu, ; Chenhui Wang,
| | - Yuanyuan Zhao
- Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, National Health Commission and Chinese Academy of Medical Sciences, Wuhan, China,*Correspondence: Nianqiao Gong, ; Yuanyuan Zhao, ; Hua Zhu, ; Chenhui Wang,
| | - Hua Zhu
- Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, United States,*Correspondence: Nianqiao Gong, ; Yuanyuan Zhao, ; Hua Zhu, ; Chenhui Wang,
| | - Chenhui Wang
- The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China,*Correspondence: Nianqiao Gong, ; Yuanyuan Zhao, ; Hua Zhu, ; Chenhui Wang,
| |
Collapse
|